Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02464657
Title Nivolumab in Acute Myeloid Leukemia (AML)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

bone marrow cancer

Therapies

Dexamethasone

Cytarabine + Idarubicin + Nivolumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.